Cargando…

Tumour Heterogeneity: The Key Advantages of Single-Cell Analysis

Tumour heterogeneity refers to the fact that different tumour cells can show distinct morphological and phenotypic profiles, including cellular morphology, gene expression, metabolism, motility, proliferation and metastatic potential. This phenomenon occurs both between tumours (inter-tumour heterog...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tellez-Gabriel, Marta, Ory, Benjamin, Lamoureux, Francois, Heymann, Marie-Francoise, Heymann, Dominique
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2016
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5187942/ https://www.ncbi.nlm.nih.gov/pubmed/27999407 http://dx.doi.org/10.3390/ijms17122142

Ejemplares similares

Circulating Tumor Cells as a Tool for Assessing Tumor Heterogeneity
por: Tellez-Gabriel, Marta, et al.
Publicado: (2019)

Receptor tyrosine kinases: Characterisation, mechanism of action and therapeutic interests for bone cancers
por: Ségaliny, Aude I., et al.
Publicado: (2015)

The Challenges of Detecting Circulating Tumor Cells in Sarcoma
por: Tellez-Gabriel, Marta, et al.
Publicado: (2016)

Isolation of circulating tumor cells in a preclinical model of osteosarcoma: Effect of chemotherapy
por: Chalopin, Antoine, et al.
Publicado: (2018)

Circulating Tumor Cell-Derived Pre-Clinical Models for Personalized Medicine
por: Tellez-Gabriel, Marta, et al.
Publicado: (2018)

Clusterin inhibition using OGX-011 synergistically enhances zoledronic acid activity in osteosarcoma
por: Lamoureux, Francois, et al.
Publicado: (2014)

Imatinib Mesylate Exerts Anti-Proliferative Effects on Osteosarcoma Cells and Inhibits the Tumour Growth in Immunocompetent Murine Models
por: Gobin, Bérengère, et al.
Publicado: (2014)

Implication of molecular vascular smooth muscle cell heterogeneity among arterial beds in arterial calcification
por: Espitia, Olivier, et al.
Publicado: (2018)

Exosomal lncRNAs: the newest promising liquid biopsy
por: Tellez-Gabriel, Marta, et al.
Publicado: (2019)

miRNA-193a-5p repression of p73 controls Cisplatin chemoresistance in primary bone tumors
por: Jacques, Camille, et al.
Publicado: (2016)

Loss of miR-198 and -206 during primary tumor progression enables metastatic dissemination in human osteosarcoma
por: Georges, Steven, et al.
Publicado: (2018)

Osteoprotegerin inhibits bone resorption and prevents tumor development in a xenogenic model of Ewing's sarcoma by inhibiting RANKL
por: Picarda, Gaëlle, et al.
Publicado: (2013)

Targeting the epigenetic readers in Ewing Sarcoma inhibits the oncogenic transcription factor EWS/Fli1
por: Jacques, Camille, et al.
Publicado: (2016)

RANK–RANKL signalling in cancer
por: Renema, Nathalie, et al.
Publicado: (2016)

Biology of Bone Sarcomas and New Therapeutic Developments
por: Brown, Hannah K., et al.
Publicado: (2017)

Anti-RANKL therapy for bone tumours: Basic, pre-clinical and clinical evidences
por: Heymann, Dominique
Publicado: (2012)

TH1579, MTH1 inhibitor, delays tumour growth and inhibits metastases development in osteosarcoma model
por: Moukengue, Brice, et al.
Publicado: (2020)

Identification of genomic differences among peripheral arterial beds in atherosclerotic and healthy arteries
por: Steenman, Marja, et al.
Publicado: (2018)

Current Therapeutic Strategies and Novel Approaches in Osteosarcoma
por: Ando, Kosei, et al.
Publicado: (2013)

Zoledronic acid inhibits pulmonary metastasis dissemination in a preclinical model of Ewing’s sarcoma via inhibition of cell migration
por: Odri, Guillaume, et al.
Publicado: (2014)

Biological evidence of cancer stem-like cells and recurrent disease in osteosarcoma
por: Jubelin, Camille, et al.
Publicado: (2022)

Bone Tumor Environment as a Potential Therapeutic Target in Ewing Sarcoma
por: Redini, Françoise, et al.
Publicado: (2015)

Drug resistance in glioblastoma: are persisters the key to therapy?
por: Oliver, Lisa, et al.
Publicado: (2020)

Dysregulation of macrophage polarization is associated with the metastatic process in osteosarcoma
por: Dumars, Clotilde, et al.
Publicado: (2016)

Technical report: liquid overlay technique allows the generation of homogeneous osteosarcoma, glioblastoma, lung and prostate adenocarcinoma spheroids that can be used for drug cytotoxicity measurements
por: Jubelin, Camille, et al.
Publicado: (2023)

Lipopolysaccharide-binding protein expression is associated to the metastatic status of osteosarcoma patients
por: Heymann, Clément J.F., et al.
Publicado: (2022)

Safety Concern between Autologous Fat Graft, Mesenchymal Stem Cell and Osteosarcoma Recurrence
por: Perrot, Pierre, et al.
Publicado: (2010)

(99m)Tc-NTP 15-5 assessment of the early therapeutic response of chondrosarcoma to zoledronic acid in the Swarm rat orthotopic model
por: Miot-Noirault, Elisabeth, et al.
Publicado: (2013)

Three-dimensional in vitro culture models in oncology research
por: Jubelin, Camille, et al.
Publicado: (2022)

In vitro three-dimensional cell cultures for bone sarcomas
por: Munoz-Garcia, Javier, et al.
Publicado: (2021)

N6-Adenosine Methylation of miRNA-200b-3p Influences Its Functionality and Is a Theranostic Tool
por: Briand, Joséphine, et al.
Publicado: (2020)

Detection and Verification of a Key Intermediate in an Enantioselective Peptide Catalyzed Acylation Reaction
por: Brauser, Matthias, et al.
Publicado: (2022)

Small animal models for the study of bone sarcoma pathogenesis:characteristics, therapeutic interests and limitations
por: Jacques, Camille, et al.
Publicado: (2018)

Cellular Heterogeneity and Cooperativity in Glioma Persister Cells Under Temozolomide Treatment
por: Rabé, Marion, et al.
Publicado: (2022)

The twin cytokines interleukin-34 and CSF-1: masterful conductors of macrophage homeostasis
por: Muñoz-Garcia, Javier, et al.
Publicado: (2021)

Advances in Osteosarcoma
por: Panez-Toro, Isidora, et al.
Publicado: (2023)

The Elderly and the COVID 19 Crisis: A Chronicle of Deaths Foretold, in Isolation and Total Indifference
por: Heymann, Dominique
Publicado: (2021)

Inhibiting Endothelin Receptors with Macitentan Strengthens the Bone Protective Action of RANKL Inhibition and Reduces Metastatic Dissemination in Osteosarcoma
por: Muñoz-Garcia, Javier, et al.
Publicado: (2022)

The Bone Niche of Chondrosarcoma: A Sanctuary for Drug Resistance, Tumour Growth and also a Source of New Therapeutic Targets
por: David, E., et al.
Publicado: (2011)

Case Report: Grade 2 Metastatic Pancreatic Neuroendocrine Tumor With Progression of One Metastasis After Pregnancy to Grade 3 Large-Cell Neuroendocrine Carcinoma: One Case Cured by Resection With Genomic Characterization of the Two Components
por: Raoul, Jean-Luc, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_2s67p85f2j845vfso2q1vsnegn